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Thirst, drinking, and arginine vasopressin (AVP) secretion are essential correlated 
osmoregulatory mechanisms that are crucial for normal physiologic function and overall 
survival of humans. These homeostatic mechanisms require or are operated via complex 
central and peripheral neural connections with influence from other peptides and hormones 
including angiotensin II, atrial natriuretic peptide and relaxin. The effectiveness of these 
mechanisms declines with age, and the consequences manifest during hyperosmotic challenges 
as decreased thirst and urine concentrating ability. The neurohumoral cascades involved in the 
physiological response to alterations in fluid and electrolyte balance are examined. 
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INTRODUCTION   
Thirst is a subjective sensation that triggers the 
conscious need for humans and animals to drink water. 
It is a major osmoregulatory mechanism involved in the 
maintenance of the body’s hydromineral balance and 
therefore, extremely necessary for normal physiologic 
functions and survival. The desire to ingest fluids 
emerges from several factors including cultural, 
habitual and psychogenic triggers. Drinking may also 
arise as a regulatory response to reductions in body 
fluid content e.g. decreased extracellular fluid (ECF) 
volume (hypovolemia) or increased osmolality 
(hypertonicity). Drinking patterns are also influenced 
by plasma levels of certain hormones involved in 
hydromineral metabolism such as angiotensin II (A-II), 
arginine vasopressin (AVP), oxytocin, atrial natriuretic 
peptide (ANP), relaxin and aldosterone (Antunes-
Rodrigues et al., 2004; Amabebe et al., 2017; Begg, 
2017). This review examines the neurohumoral 
mechanisms   involved in the  regulation  of  human’s 
desire to drink water or fluid (thirst). Both the 
extracellular and intracellular compartments contribute 
 
 to total body water loss but to varying degrees. 
Concurrent loss of NaCl (the major solute of the ECF) 
and water results in proportionately more ECF 
depletion than water loss alone. This is obvious in 
conditions of vomiting and diarrhoea where fluid is lost 
from the gastrointestinal tract. Loss of isotonic fluid 
usually occurs from the ECF compartment. However, 
an osmotic depletion of water from the intracellular 
fluid (ICF) compartment into the ECF leading to 
volume expansion occurs when hypertonic fluid is 
added to the extracellular compartment (McKinley and 
Johnson, 2004). 
Several adaptive regulatory responses are employed 
during volume depletion of either the ICF or ECF. 
These responses which include activation of the renin-
angiotensin system (RAS), AVP release, sympathetic 
activation, and increased renal sodium and water 
reabsorption, have the adaptive tendency of curtailing 
alterations in volume and composition of body fluid. 
Although of undoubted benefit to the animal, these 
mechanisms do not completely restore body fluids to 
the original state. Consequently, restoration of fluid 
deficit through drinking becomes inevitable. Therefore, 
thirst, which provides the conscious desire to acquire 
and ingest water, is a vital component of the closely 
regulated physiological mechanisms that maintain 
water and electrolyte homeostasis (Amabebe et al. 
2017; Begg, 2017; McKinley and Johnson, 2004; 
Stachenfeld, 2014). 
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Osmoregulatory thirst and cellular dehydration 
As little as 1–2% increase in the effective plasma 
osmotic pressure stimulates thirst in mammals 
(Fitzsimons, 1998; McKinley and Johnson, 2004), and 
this relationship is directly proportional, i.e. thirst 
perception increase with increase in plasma osmolality 
(Ramsay and Thrasher, 1991). When the plasma 
osmolality (280–295 mOsmol/kgH2O) is increased 
experimentally by increasing the concentration of 
solutes such as NaCl or sucrose that do not readily 
permeate cell membranes, thirst is stimulated. In 
contrast, systemic infusion of hypertonic solutions that 
more readily permeate nerve cell membranes (such as 
urea or D-glucose solutions) is relatively less effective 
in stimulating thirst (Fitzsimons, 1979; McKinley et al., 
1978; Zerbe and Robertson, 1983). In the former case, 
a transmembrane osmotic gradient is created resulting 
in cellular dehydration as water moves out of the cells 
by osmosis whereas cellular dehydration does not occur 
with the permeating solutes.   
Specialized sensory brain cells respond to cellular 
osmolar changes to stimulate neural mechanisms that 
generate thirst and are termed osmoreceptors 
(Fitzsimons, 1979; Zerbe and Robertson, 1983). 
Although some osmoreceptors are located in the 
gastrointestinal tract, liver and kidneys, a significant 
amount of osmoreceptive neurons are found in the 
brain’s preoptic/hypothalamic region. The likelihood of 
a more rostral tissue in the anterior wall of the third 
ventricle as the location of osmotic thirst-mediating 
sensors in relation to plasma and cerebrospinal fluid 




Neural control of osmotically-induced thirst  
Cerebral osmoreceptors capable of detecting body fluid 
osmolar changes and subsequently mediating thirst and 
AVP release are present in brain regions without the 
normal blood-brain barrier (BBB) (McKinley et al., 
1978). The neurons in the circumventricular organs 
(CVOs) i.e. the vascular organ of the lamina terminalis 
(OVLT) and subfornical organ (SFO) that lack BBB 
are confirmed locations of highly specialised and 
sensitive osmoreceptors (Fig. 1). The CVOs are located 
in the lamina terminalis, which forms the anterior wall 
of the third ventricle (Andersson, 1978; Antunes-
Rodrigues et al., 2004; Fitzsimons, 1998; Johnson et 
al., 1996; McKinley et al., 2003; McKinley et al., 
2004), and well positioned (especially the SFO) to 
mediate both blood-borne (e.g. A-II, Na+) and central 
nervous system (CNS, e.g. renin, A-II) osmoregulatory 
signals (Coble et al., 2015).  
In addition, osmoreceptors have been identified in the 
median preoptic nucleus (MnPO), an integral part of 
the anteroventral third ventricle (AV3V) region, 
situated longitudinally between the two CVOs in the 
lamina terminalis but within the BBB. It is also 
activated by osmotic stimuli due to the presence of 
angiotensin type 1 receptor (AT1R) - a G-protein 
coupled receptor (Johnson et al., 1996; McKinley and 
Johnson, 2004). The MnPO can initiate thirst in 
response to both osmotic and endocrine stimulations 
relayed to it by projections from the SFO and OVLT 
(Fitzsimons, 1976; Johnson et al., 1996). A central 
angiotensinergic pathway is involved in 
osmoregulatory drinking as the MnPO receives 
descending angiotensinogernic signals (synapses) from 
the SFO (Johnson et al., 1996). 
 
The MnPO receives osmotically-induced afferent 
neural inputs from neurons in both CVOs and integrate 
these signals with volumetrically-induced visceral 
sensory afferents from the hindbrain structures (Fig. 1). 
In addition, the desire to drinking is reduced but not 
abolished even after combined ablation of both CVOs 
with a considerable part of the MnPO intact. This 
suggests that osmoreceptive neurons may also be found 
in the MnPO and/or osmotic signals from other parts of 
the brain, e.g., the nucleus tractus solitaries (NTS) and 
area postrema (AP), or within the body (e.g., hepatic 
portal system) may be integrated in this region 




The lamina terminalis is clearly the brain region where 
blood-borne stimuli including hypertonicity or 
hormones (e.g., A-II, ANP and relaxin), exert their 
dipsogenic action. Subsequent efferent neural pathways 
project from the lamina terminalis to other brain 
regions including the anterior cingulate and insular 
cortices to initiate and modify the thirst sensation and 
drinking (McKinley et al., 2003; McKinley et al., 2004; 
Stachenfeld, 2014). Drinking rapidly decreased the 
neural activities in these areas (McKinley et al., 2003). 
The lamina terminalis also sends neural inputs to the 
lateral hypothalamic area (LHA), paraventricular 
nucleus (PVN) and supraoptic nucleus (SON), which 
are believed to participate in generation of thirst (Fig. 




ECF can be depleted selectively without concomitant 
reduction in ICF. The ECF is depleted pathologically 
by excessive bleeding (haemorrhage), increased sodium 
and water excretion or accumulation of fluid in the 
interstitium or body cavities (oedema); and 
experimentally by fluid restriction, furosemide 
treatment and intraperitoneal polyethylene glycol 
injection (Coble et al., 2015). 
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Fig. 1. Osmoregulatory neuroendocrine control of thirst and arginine vasopressin secretion. Osmoreceptors in the subfornical 
organ (SFO) and vascular organ of the lamina terminalis (OVLT) respond to cellular dehydration by stimulating thirst, drinking 
and arginine vasopressin (AVP) secretion via signals to the median preoptic nucleus (MnPO, angiotensinergic afferents), 
lateral hypothalamic area (LHA), and the supraoptic (SON) and paraventricular (PVN) nuclei. Similarly, extracellular (EC) 
dehydration is detected by peripheral baro- and visceral osmoreceptors and transmitted via the glossopharyngeal (CNIX) and 
vagus (CNX) nerves to the nucleus tractus solitarius (NTS) and area postrema (AP). These hindbrain nuclei stimulate drinking 
and water retention via connection with neurons of the lamina terminalis and hypothalamus. They can also send inhibitory 
signals through the lateral parabrachial nucleus (LPBN) to prevent excessive drinking and volume expansion after stimulation 
of specific thirst pathways. In addition, in response to decreased blood volume and pressure, the renin-angiotensin system 
(RAS) is activated and angiotensin II is produced which stimulates thirst by acting on angiotensin type 1 receptor (AT1R) on 
the circumventricular organs (CVOs). Relaxin has a similar dipsogenic effect on the CVOs; while atrial natriuretic peptide 
(ANP) is inhibitory. The eventual generation of thirst and drinking is also modified by inputs from higher centres including the 
anterior cingulate and insular cortices. Adapted from: Amabebe et al., 2017 and McKinley and Johnson, 2004. 
 
 
The body responds to the resultant hypovolemia or 
extracellular dehydration by activating components of 
the neuroendocrine systems to mitigate the 
consequences of decreased cardiac output and declining 
blood pressure. These include activation of the 
sympathetic nervous system, which increases vascular 
tone, venous return, cardiac output, and reduces renal 
sodium and water excretion. Also, there is increase in 
plasma AVP, central and peripheral RAS components, 
catecholamines, adrenocorticotrophic hormone 
(ACTH), and glucocorticoids (cortisol) that stimulate 
various mechanisms to preserve sodium and water or 
redistribute blood and interstitial (ISF) to maintain 
adequate supply to vital organs such as the brain and 
heart. As these adaptive mechanisms do not completely 
replenish the body’s hydromineral deficits, absolute 
correction involving the initiation of behaviours 
associated with obtaining and ingesting water 
(drinking) and sodium (salt appetite) becomes 
inevitable. The initiation of behaviours to correct ECF 
volume deficits is similar to the sympathetic and 
endocrine responses to extracellular dehydration. Both 
effector systems require information reflecting the 
status of blood and/or ISF volumes to be integrated in 
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the CNS through both endocrine and visceral afferent 
pathways (McKinley and Johnson, 2004; McKinley et 
al., 2006). 
 
Angiotensin-induced thirst  
Hypovolemia results in reduced renal perfusion and 
increased sympathetic stimulation of the 
juxtaglomerular cells of the kidney (Fitzsimons, 1998). 
This leads to the production of renin 
(angiotensinogenase) and the synthesis of its effector 
peptide, A-II from angiotensinogen and angiotensin I. 
Systemic administration of both the renin and A-II 
generate drinking in satiated animals. Similar to 
osmotically-induced drinking, A-II-induced thirst 
requires the nuclei of the lamina terminalis particularly 
the SFO that has high density of ATIR (Sakai et al., 
2007) for initial CNS processing and integration of this 
peripherally derived impulse (Johnson et al., 1996). 
 
A more profound dipsogenic effect is observed by 
central (brain) injection of A-II into the lateral ventricle 
or SFO via interaction with ATIR (Coble et al., 2014a; 
Coble et al., 2014b). Components of the RAS such as 
renin, angiotensinogen, angiotensin I (A-I) and A-II are 
also produced by the SFO in response to increase in 
osmolar concentration of CSF, a protein-free derivative 
of plasma. SFO-generated A-II is sufficient to initiate 
drinking via protein kinase-Cα independently. 
However, the overall effect is determined by the 
expression levels of A-II receptors on the SFO and 
MnPO (Agassandian et al., 2017; Coble et al., 2014a; 
Coble et al., 2014b; Sakai et al., 2007). Circulating A-
II acts on forebrain CVOs as an endocrine factor; and it 
activates angiotensinergic pathways projecting to 
central integrative regions in an autocrine or paracrine 
fashion (Johnson and Thunhorst, 1997; Lavoie and 
Sigmund, 2003) e.g. as the neurotransmitter for 
descending nerve impulses from the SFO to the MnPO 
(McKinley and Johnson, 2004).  
The MnPO has high concentration of AT1R but unlike 
other structures of the lamina terminalis, it is not 
exposed to circulating A-II as it is inside the BBB (Fig. 
1). Hence, its activities are influenced by 
angiotensinergic afferent neural inputs from the CVOs 
(McKinley et al., 2006). There are also ATIRs on 
postsynaptic neurons in the SON and PVN, which 
receive afferents from the SFO (Agassandian et al., 
2017; Gonzalez et al., 2012). Osmotic stimulation also 
increases angiotensin-(1-7) A-(1-7) production. A-(1-7) 
is synthesised by type 2 angiotensin converting enzyme 
from A-II or A-I, and acts through MAS receptors 
found in forebrain structures (e.g. diencephalon and 
cerebral ventricles). It increases osmotically-induced 
water intake but not at basal conditions (dos-Santos et 
al., 2017). Although the systemic and central RAS are 
distinct, their roles in the maintenance of body fluid 
balance are complementary. Further reading on the 
central RAS can be found in Antunes-Rodrigues et al. 
2004. 
 
Thirst perception and estimated plasma AVP 
concentration 
 Thirst is a “generalized deep-seated feeling of a desire 
for water” (Robertson, 1984). Thirst is distinct from 
drinking which is the actual fluid intake. Drinking is a 
behavioural mechanism influenced by several factors 
including age, personal, environmental and cultural 
factors. Oral ingestion of distilled water or hypertonic 
fluid and overnight 18-hour water deprivation to induce 
dehydration show a consistent thirst perception in man 
(Obika et. al., 2009; Obika et al., 2013; Obika and 
Ozoene, 2014). Thirst sensation is stimulated by 
increase in plasma osmolality (hypertonicity, 
dehydration), decrease in blood volume and pressure 
(hypovolemia and hypotension), stimulation of the 
RAS and increase in central and circulating A-II and 
dryness of mouth (Baylis and Ball, 2013). Hence, thirst 
perception is a subjective feeling of the need to drink 
water.   
 
Attempts have been made to assess and relate thirst 
perception (TP) and plasma AVP concentration. 
Experimentally, acute changes in thirst are measured 
using a geometric rating scale called the Visual 
Analogue Scale (VAS) (Thompson and Campbell, 
1997; Thompson et. al., 1991; Takamata et. al., 1994). 
This is obtained by asking study participants to indicate 
how thirsty they are by making a mark across an 
uncalibrated 10 cm line with it ends marked “very 
thirsty” and “not thirsty”. It has been shown that TP 
ratings so obtained correlate with plasma AVP 
concentration and plasma osmolality in various 
physiological states in man (Amabebe et al., 2012; 
Obika et al., 2013; Obika and Ozoene, 2014).  
 
Hindbrain regulation of thirst  
To balance the neurohumoral signals that facilitate 
drinking, there are both stimulatory and inhibitory 
inputs acting on or through the hindbrain structures 
including the AP, medial NTS and lateral parabrachial 
nucleus (LPBN) to the MnPO (Fig. 1) (McKinley and 
Johnson, 2004; McKinley et al., 2006). Both arterial 
baroreceptors and volume cardiopulmonary receptors 
are capable of transmitting inhibitory thirst signals from 
the great veins and pulmonary arteries. Mechanical 
stretching of the arterial baroreceptors and 
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cardiopulmonary receptors attenuates experimentally 
induced drinking, while drinking is stimulated when 
reduced venous return to the heart is detected by both 
set of receptors (Fitzsimons and Moore-Gillion, 1980; 
Thrasher et al., 1982). Similarly, denervation of either 
the cardiopulmonary or sinoaortic baroreceptors 
significantly attenuates thirst while denervation of both 
sets of receptors completely abolishes drinking even 
with elevated circulating levels of A-II (Quillen et al., 
1988). 
 
Afferent signals from the cardiopulmonary and arterial 
baroreceptors are transmitted to the brain by the 
glossopharyngeal (IX) and vagus (X) cranial nerves, 
with most of these nerves terminating in the NTS 
(McKinley and Johnson, 2004) (Fig. 1). Lesions of the 
AP and NTS, result in exaggerated response to thirst-
inducing hypovolemic stimulations (Edwards and 
Ritter, 1982; Wang and Edwards, 1997). These effects 
are plausibly due to loss of inhibitory input from the 
baroreceptors that are integrated in the NTS from 
where they are relayed to the forebrain structures via 
the LPBN (McKinley and Johnson, 2004; McKinley 
and Johnson, 2006). It is also possible that the AP 
exercise some form of inhibitory control over thirst 
induced by systemic blood volume expansion or acute 
increase in blood pressure (McKinley and Johnson, 
2004) (Fig. 1). Also, atrial natriuretic peptide (ANP), a 
peptide hormone released from the cardiac atria inhibits 
thirst sensation and drinking in response to 
hypervolemia and hypertension by acting on the SFO 
(Antunes-Rodrigues et al., 1985; Antunes-Rodrigues et 
al., 2004). The action of ANP is discussed in more 
details below. 
 
Because the AP-NTS region contains neuronal 
projections to the LPBN (McKinley and Johnson, 
2004), lesions of the LPBN also produce excessive 
drinking to mediators of extracellular dehydration 
(Johnson and Thunhorst, 1997). A significant portion of 
the efferents from the AP-NTS to the LPBN contain 
serotonin (5-HT) (McKinley and Johnson, 2004), and 
bilateral injections of a non-selective 5-HT receptor 
antagonist, promote drinking and salt appetite in 
response to several thirst stimuli. In essence, the AP, 
NTS, and LPBN form a hindbrain inhibitory circuit that 
integrates osmoregulatory neuroendocrine signals 
derived from activation of peripheral visceral and 
baroreceptors and project same to the forebrain 
structures including the lamina terminalis and various 
hypothalamic nuclei that are associated with the thirst 
response (McKinley and Johnson, 2004). In turn, the 
LPBN and NTS receive reciprocal connections from 
many of the forebrain structures. Thirst and drinking 
behaviours are controlled within this visceral-neural 
network with projections from both excitatory and 
inhibitory endocrine and visceral afferent nerves.  
 
Furthermore, thirst is stimulated by oral or intragastric 
sodium loading detected by oropharyngeal (Robertson, 
1984; Obika et al., 2014) and abdominal viscera 
receptors, such as gastric, hepatic portal and renal 
osmoreceptors, before any substantial increase in 
systemic plasma osmolality (Stricker et. al., 2002). The 
response is promoted by simultaneous activation of the 
central osmoreceptors by dehydration and salt loading. 
Other integrative sites related to thirst and fluid intake 
includes the middle dorsal and median raphe nuclei 
(inhibitory), lateral preoptic region (osmoreception) 
and the septal region (both excitatory and inhibitory) 
(McKinley et al., 2006). 
 
Other thirst regulating hormones 
Several other peptide and steroid hormones influence 
thirst. Some peptides e.g., relaxin (Baylis and Ball, 
2013) and orexin (Hurley and Johnson, 2014) stimulate 
water intake, whereas others e.g., glucagon-like 
peptide-1 inhibit drinking (McKay et al., 2014). Like 
the ANP, relaxin acts on the SFO of the lamina 
terminalis though in an antagonistic manner (Antunes-
Rodrigues et al., 2004; McKinley and Johnson, 2004). 
 
Arginine vasopressin (AVP)  
AVP (antidiuretic hormone, ADH) is a nine amino 
acids peptide with a disulphide bridge linking the 
cysteine residues at positions 1 and 6 (Baylis and Ball, 
2013). It is similar to oxytocin, differing only by two 
amino acids in position 3 – phe, and 8 – Arg. AVP is 
produced by the SON and PVN of the hypothalamus 
(Baylis and Ball, 2013; Amabebe et al., 2017). Smaller 
amounts are also produced locally in many tissues 
outside the hypothalamus. As a result AVP also 
perform autocrine and paracrine functions in addition to 
its endocrine effect. The hypothalamic vasopressinergic 
magnocellular neurons containing AVP terminate in the 
posterior pituitary (neurohypophysis) where AVP is 
stored prior to secretion. Some vasopressinergic 
neurons also innervate other areas of brain and spinal 
cord enabling AVP to exert both systemic and local 
actions in the CNS (Mavani et al., 2015), e.g. AVP 
exerts is role in the regulation of ACTH release via the 
vasopressinergic parvocellular neurons that project to 
the hypophyseal-portal bed of the anterior pituitary 
(adenohypophysis) and secrete both AVP and 
corticotropin-releasing hormone (CRH) (Baylis and 
Ball, 2013).  
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The most sensitive stimulus for AVP secretion is an 
increase in plasma osmolality. Although AVP release is 
also stimulated by hypovolemia and hypotension, these 
stimuli require greater (5-10%) variations than changes 
in plasma osmolality (Robertson, 1975; Baylis and 
Ball, 2013). Increase in plasma osmolality produce a 
linear increase in AVP concentration (Baylis and Ball, 
2013), while drinking abolishes the relationship 
between plasma osmolality and AVP release. AVP is 
central to the integrated neuroendocrine pathway 
involved in the physiological and pathophysiological 
adaptations to hypovolemia. A-II and relaxin stimulate 
AVP magnocellular neurons in the hypothalamus while 
ANP inhibits AVP neuron activity (Baylis and Ball, 
2013).  
The physiological concentration of plasma AVP is less 
than 2 pg/ml., making it quite difficult to measure. 
Being a small peptide, it is readily filtered through the 
glomeruli and excreted unchanged in the urine because 
it is not metabolised by the kidney. Copeptin, a more 
stable peptide with longer half-life and secreted along 
with AVP in equimolar amounts is used as a surrogate 
marker for estimating AVP secretion (Andersen et al., 
1990). It is actually derived from the C-terminus of pre-
pro-hormone of AVP, neurophysin II and copeptin and 
secreted by the hypothalamic PVN and SON (Acher et 
al. 2002). Copeptin levels correlate with AVP 
concentrations (Mavani et al., 2015). 
AVP acts mainly via its tissue-specific G protein-
coupled receptors located in the CNS as well as 
peripheral organs (Holmes et al., 2003). These 
receptors subtypes include V1a, V1b (V3), and V2. 
V1a receptors are present in several tissues including 
the blood vessels, brain, adipose tissue, adrenal cortex, 
uterine smooth muscle cells, liver, cardiac myocytes, 
osteoblast and osteoclast. V1b receptors presently 
known as V3 receptors are mainly found in 
adenohypophysis, adrenal medulla, pancreatic islet 
cells of Langerhans, and white adipose tissue. V2 
receptors that mediate the well-known AVP-stimulated 
water reabsorption from the kidneys (antidiuresis) 
(Holmes et al., 2003) are located in the basolateral 
membrane of the renal collecting duct, alveolar 
epithelium, vascular smooth muscle cell, osteoblast and 
osteoclast (Holmes et al., 2003; Koshimizu et al., 
2012).  
As a result of the widespread distribution of its receptor 
subtypes both centrally and peripherally, AVP mediates 
several other profound non-pressor and non-antidiuretic 
actions (Mavani et al., 2015). These actions include 
bone formation, glycolysis, lipid metabolism, diabetes, 
metabolic syndrome, infection, inflammation, cellular 
proliferation, cognition, social and emotional 
behaviour, pain, aging, hypothalamic-pituitary-adrenal 
axis and chronic kidney disease. These effects of AVP 
are reviewed in detail by (Mavani et al., 2015). 
The effects of osmotic stimuli (hypertonic NaCl 
infusion) on thirst perception (TP) and plasma AVP 
concentration (PAVP) at various times in healthy adults 
was examined and expressed mathematically in relation 
to plasma osmolality (Posm) as:  
 
PAVP = 1.48 (Posm - 284.7) and, 
 
TP = 9.06 (Posm - 293.5) (Robertson, 1984) 
 
The osmotic threshold for the onset of thirst was 293.5 
mOsm/kgH2O, ~10 mOsm/kgH2O greater than the 
osmotic threshold for AVP release. This implies thirst 
sensation will not often be felt when plasma osmolality 
is within the physiological range of 280 - 295 
mOsm/Kg H2O (Robertson, 1984), at least until after 
the antidiuretic effect of AVP is exhausted.   
 
Thirst is primarily stimulated by an increase in plasma 
osmolality, which is regulated by changes in blood Na+ 
concentration. Oral hypertonic fluid ingestion and fluid 
restriction consistently produce an increase in thirst 
perception (Obika et. al., 2009; Obika et al., 2013). 
However, voluntary ingestion of salt loads e.g. salted 
nuts containing 3.5 or 4.4 g NaCl for men and 1.9 or 
3.7 g for women, did not increase thirst or drinking 
after 2 hours (Micah, 2014). This is contrary to the 
widely reported relationship between ingestion of 
hypertonic solution, dehydration and increase in thirst 
perception (Barney, 1997; Kenefick et al., 2006; Obika 
et al., 2009; Obika et al., 2013; Obika et al., 2014; 
Riebe et al., 1997). Using nuts as a means of 
experimental salt loading highlighted methodological 
concerns (Micah, 2014), and warrants further 
investigation.  
Thirst perception ratings obtained by the VAS could be 
related to plasma AVP concentrations in normal 
subjects (Igbokwe and Obika, 2008). Plasma AVP 
concentration measured by enzyme-linked 
immunosorbent assay (ELISA) is also clearly related to 
thirst perception in humans (Amabebe et al., 2012). 
Furthermore, indirect estimation of AVP levels from 
thirst perception ratings and plasma osmolality values 
in euhydrate, dehydrated and rehydrated individuals 
have been reported (Obika and Ozoene, 2014). 
Therefore, thirst and AVP mechanisms operate in a 
complementary manner to regulate body fluid volume 
and osmolar concentration. Alterations of the normal 
secretion or function of AVP can result in profound 
disturbances in hydromineral homeostasis (Mckenna 
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and Thompson, 1998). Plasma AVP measurement is 
used clinically for diagnosis of conditions such as 
syndrome of inappropriate ADH secretion (SIADH), 
diabetes insipidus, ectopic AVP production and 
psychogenic water intoxication (Haynes, 1958).  
 
Atrial natriuretic peptide (ANP)  
ANP is synthesized and released by cardiac myocytes 
in the wall of the atria of the heart. It prevents over-
expansion of ECF volume by increasing renal Na+ 
excretion (natriuresis). Increase in ECF or blood 
volume cause mechanical stretching of the atria and 
eventual secretion of ANP. Endothelin stimulates, 
while nitric oxide inhibits ANP secretion (Dietz, 2005). 
ANP has a potent inhibitory action on thirst sensation, 
drinking (Burrell et al., 1992), and AVP secretion 
(Baylis and Ball, 2013). Interestingly, this 
antidipsogenic action appears to be directed primarily 
against A-II-stimulated drinking, although it also 
inhibits osmotically-induced thirst e.g. injection of 
ANP into the SFO inhibits A-II-stimulated thirst and 
water intake (Ehlich and Fitts, 1990), via its receptors 
in the CVOs of the lamina terminalis. 
 
Relaxin  
Relaxin is synthesized and secreted in the female by the 
corpus luteum of the ovary, and during pregnancy by 
the gestational tissues including the placenta, chorion 
and decidua.  It is also produced in the prostate and 
present in seminal fluid in males (MacLennan, 1991). 
Relaxin influences body fluid and electrolyte balance 
by stimulating AVP secretion and water intake by 
acting centrally or systemically. Significant amounts of 
relaxin receptors are found in both the SFO and OVLT, 
and were presumed to be the sites of its dipsogenic 
action (Osheroff and Phillips, 1991). However, 
subsequent ablation of the SFO, sparing the OVLT, 
abolished water intake in response to i.v. relaxin, 
indicating that the SFO is the preferred site of action of 
blood-borne relaxin (McKinley et al., 2006). A-II and 
relaxin may act synergistically to enhance thirst during 
pregnancy because circulating A-II potentiates the 
dipsogenic action of i.v. relaxin (Sinnayah et al., 1999; 
McKinley et al., 2006).  
 
In pregnancy, plasma osmolality decreases by ~10 
mOsm/kgH2O in some species, including humans 
(Lindheimer and Davison, 1995; Amabebe et al., 
2017). In such instance, thirst perception should 
diminish. However, water intake remains unchanged or 
may even increase in some instances despite the 
prevailing plasma hypotonicity. This is attributable to 
the dipsogenic effect of high level of relaxin during 
pregnancy. It is also suggested that there is a 
corresponding resetting of the central osmostat 
(osmotic thresholds) regulating thirst and AVP 
secretion plausibly due to central actions of relaxin and 
oestrogen (Stachenfeld, 2014). A new steady state is 
eventually established and the volume-determined AVP 
release mechanism is adapted to suit pregnancy needs 
(increased fluid retention), which is maintained until 
birth (Lindheimer and Davison, 1995). The resultant 
expanded blood volume is consequently acknowledged 
as normal (Barron, 1987). This transient hemodilution 
could be in response to rising oestrogen levels 
(Stachenfeld, 2014), however, this phenomenon 
requires further evaluation. 
 
Oestrogen 
The luteal phase of the menstrual cycle is characterised 
by high levels of oestrogen, progesterone and plasma 
RAS activity. The RAS components are also elevated 
in young women on oestrogen and progesterone 
contraceptive pills and a similar effect is seen in 
postmenopausal women receiving oral oestrogen 
replacement therapy. Oestrogen upregulates the gene 
expression of angiotensinogen in the liver and brain 
(Boschitsch, et al., 2010; Greenland and Sernia, 2004; 
Kuroski de Bold, 1999; Stachenfeld, 2008, Stachenfeld, 
2014). 
Contrastingly, oestrogen also downregulates RAS 
activity by indirectly decreasing plasma renin 
concentration via a decrease in circulating adrenaline 
and noradrenaline (Amabebe and Robert, 2017; 
Schunkert et al., 1997). It also attenuates RAS activity 
by inhibiting ATIR and angiotensin converting enzyme 
(ACE) expression in thirst-associated brain centres 
such as the SFO (Dean et al., 2006; Gallagher et al., 
199; Kisley et al., 1999a; Krause et al., 2006). 
Oestrogen replacement decreases spontaneous and A-
II‐induced water intake and salt appetite (Kisley et al., 
1999b; Mecawi et al., 2007, Mecawi et al., 2008). 
Therefore, A-II, blood pressure and plausibly thirst 
sensation are usually maintained at normal levels 
during the luteal phase of the menstrual cycle and other 
high oestrogen states despite an increase in 
angiotensinogen levels (Amabebe and Robert, 2017; 
Boschitsch, et al., 2010; Greenland and Sernia, 2004; 
Oelkers, 1996). Also, we have recently observed a non-
significant increase in thirst during the follicular phase 
of the menstrual cycle until ovulation and a decrease 
thereafter (Nzoputam et al., under review). 
Additionally, in rats, cerebral angiotensinogen 
concentrations are highest in the oestrus phase and 
lowest in the metoestrus phase corresponding with the 
cyclical fluctuations in oestrogen (Greenland and 
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Sernia, 2004). Whether oestrogen exerts its 
antidipsogenic effects during early follicular phase in 
humans remains unresolved. 
Both ATIR and oestrogen receptors (ERα) are present 
in the SFO of the lamina terminalis (Fig. 2). Oestrogen 
inhibits the binding of A-II to AT1R and reduces the 
expression of AT1R in the SFO (Fujisawa et al., 2001; 
Kisley et al., 1999a; Rosas-Arellano et al., 1999; 
Tanaka et al., 2001). It reduces the sensitivity of the 
SFO and possibly other structures of the lamina 
terminalis to A-II stimulation, thereby attenuating the 
thirst and drinking responses (Fig. 2).    
The anti-dipsogenic and anti-natriorexigenic effects of 
oestrogen are also possibly mediated via ERs on 
multiple hypothalamic nuclei including the SON, PVN, 
medial preoptic area (mPOA), LHA; and other regions 
of the lamina terminalis i.e. OVLT and MnPO. These 
brain areas including the SFO differentially express 
ERs (Table 1) (Amabebe and Robert, 2017; Santollo 
and Daniels, 2015). 
In addition, oestrogen replacement in postmenopausal 
women increases circulating ANP. ANP inhibits the 
central action of A-II on the SFO and downregulates 
renin and ACE activities as well as AT1R expression 
and binding (Amabebe and Robert, 2017; Maffei et al., 
2001). 
 
Table 1: Distribution of oestrogen receptors in specific 
hypothalamic nuclei and the lamina terminalis 
Brain nuclei Receptor subtype 
Subfornical organ ERα 
Vascular organ of the      
lamina terminalis 
ERα, ERβ 
Median preoptic nucleus ERα, ERβ 
Lateral hypothalamus ERα, ERβ 
Medial preoptic area ERα, ERβ 
Arcuate nucleus ERα, ERβ 
Supraoptic nucleus ERα, GPER-1 
Paraventricular nucleus ERα, GPER-1 
Nucleus tractus solitaries ERα, ERβ, GPER-1 
Dorsal raphe ERβ 
ER: oestrogen receptor; GPER: G protein-coupled 
oestrogen receptor 1. 
Adapted from: Amabebe and Robert, 2017. 
 
 
Age-related osmoregulatory changes 
There is a characteristic reduction in homeostatic 
capacity with aging (Rolls and Philip, 1990). Though 
hydromineral balance is usually adequate in healthy 
independent older adults, in conditions of hypovolemia 
and hyperosmolality such as during fluid restriction, 
hypertonic saline infusion, exercise in warm climates 
or thermal dehydration, they exhibit decreased thirst 
and fluid intake (Beggs, 2017; Kenney and Chiu, 2001; 
Rolls and Philip, 1990) (Fig. 3).  
The elderly are more susceptible to dysfunctional fluid 
and electrolyte balance, which manifest usually as 
dehydration (Fig. 3), and sometimes water overload and 
hyponatremia, due to several age-related 
osmoregulatory neuroendocrine changes associated 
with water intake and excretion (Begg, 2017; Rolls and 
Philip, 1990). Some of the age-related endocrine 
changes include decreased RAS activity and elevated 
circulating ANP and AVP levels (Begg, 2017) (Fig. 3). 
Complete restoration of fluid balance after osmotic 
stimulation is slower than in younger adults (Kenney 
and Chiu, 2001).  
 
 
Fig. 2. Anti-dipsogenic action of oestrogen. Oestrogen 
decreases the expression of angiotensin II (A-II) and 
angiotensin type I receptors (AT1R) on the subfornical organ 
(SFO), vascular organ of the lamina terminalis (OVLT), and 
median preoptic nucleus (MnPO), and inhibits the binding of 
A-II to AT1R. It also increases the release of atrial natriuretic 
peptide (ANP) and directly inhibits oestrogen receptors 
(ERα) on the structures of the lamina terminalis. ANP 
antagonises the action of A-II on the SFO. Consequently, 
thirst sensation and fluid intake are reduced. These effects 
can also be seen in postmenopausal women receiving 
exogenous oestrogen. Adapted from: Amabebe and Robert, 
2017. 
The elderly show impaired response to 
dehydration/hypertonicity-induced reduction in ECF 
volume. This age-related deficient osmoregulatory 
adaptation is attributed to decreased sensitivity of the 
low and high-pressure baroreceptors (Philip et al., 
1993), and/or dysfunctional thirst integrating brain 
centres (Begg, 2017). Their kidneys also have 
inadequate water retention capacity secondary to 
relative resistance to AVP stimulation (Philip et al., 
1993). Ultimately, there is reduction in their ability to 
Thirst and AVP activity 
 
9    J. Afr. Ass. Physiol. Sci. 6 (1): 2018    Aloamaka et al. 
 
 
concentrate urine (Begg, 2017) (Fig. 3). Although, 
these observations appear convincing, there are still 
studies with contrasting opinions i.e. greater thirst 
sensation in the elderly compared to younger study 
participants secondary to hyperosmotic stimulation. 
 
                       
 
Fig. 3. Age-related impaired osmoregulatory mechanisms 
and increased susceptibility to dehydration. There is 
reduction in the functional capacity of the central neural 
connections that regulate thirst and drinking. This is 
accompanied by decreased arterial baroreceptor sensitivity 
and decreased renin-angiotensin system (RAS) activity. 
There is also increased levels of plasma atrial natriuretic 
peptide (ANP) that inhibits thirst perception. Though 
arginine vasopressin (AVP) levels could either be increased 
or decreased, the kidneys are usually unresponsive to AVP 
activities. This altered osmoregulation, which becomes 
obvious when the elderly are exposed to hypertonic or 
hypovolemic stimulation culminates in reduced thirst, fluid 
intake and ability to produce concentrated urine thereby 
predisposing them to dehydration.  
 
These opposing views have been attributed to 
variations in the method of hyperosmotic stimulation 
employed such as overnight fasting (dehydration) or 
infusion/injection of hypertonic solution (Begg, 2017). 
Future investigation involving the application of both 
methods in the same individuals (elderly vs. younger 
population) and environment at different times could 
resolve these discrepancies.  
In summary, thirst, drinking and vasopressin secretion 
are essential processes for osmoregulation, which is 
critical to the overall survival of humans. These 
homeostatic mechanisms require or are operated via 
complex but complementary central and peripheral 
neural connections with influence from other peptides 
and hormones and could be affected by several factors 
including aging.  
 
Abbrevations 
ACE, angiotensin converting enzyme; ADH, 
antidiuretic hormone; A-I, angiotensin I; A-II, 
angiotensin II; A-(1-7), angiotensin-(1-7); ANP, atrial 
natriuretic peptide; AP, area postrema; AT1R, 
angiotensin type 1 receptor; AVP, arginine vasopressin; 
BBB, blood brain barrier; CRH, corticotropin-releasing 
hormone; CSF, cerebrospinal fluid; CVO, 
circumventricular organ; ECF, extracellular fluid; ER, 
oestrogen receptor; ICF, intracellular fluid; i.v., 
intravenous; LHA, lateral hypothalamic area; LPBN, 
lateral parabrachial nucleus; MnPO, median preoptic 
nucleus; NTS, nucleus tractus solitarius; OVLT, 
vascular organ of the lamina terminalis; PVN, 
paraventricular nucleus; RAS, renin-angiotensin 
system; SFO, subfornical organ; SON, supraoptic 
nucleus; VAS, Visual Analogue Scale. 
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